Effects of oral nutritional supplements on the nutritional status and inflammatory markers in patients on maintenance dialysis: a systematic review and meta-analysis of randomized clinical trials
Authors:
Open Access
- 27 May 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 16 (11) , 2271-2288
Abstract
Background and aims: Patients on hemodialysis (HD) or peritoneal dialysis (PD) often have insufficient energy and protein intake, resulting in poor nutritional status and adverse outcomes. Oral nutritional supplements (ONSs) are the most commonly used to increase such patients’ energy and protein intakes. Methods: In this systematic review and meta-analysis, we analyzed studies on nutritional status, inflammatory markers, and electrolyte levels in patients on dialysis receiving ONSs. We searched four electronic databases from inception until 31 December 2022, for randomized controlled trials comparing ONS treatment versus placebo or routine care. Results: 22 studies with 1185 patients on dialysis were included in our meta-analysis. Compared with the control group, the ONS group exhibited significantly increased serum albumin levels [1.26 g/l (95%CI, 0.50–2.02, P < 0.0001; I2 = 80.4%)], body mass indexes (BMIs) [0.30 kg/m2 (95%CI, 0.09–0.52, P = 0.005; I2 = 41.4%)], and handgrip strength (HGS) [0.96 kg (95%CI, 0.07–1.84, P = 0.034; I2 = 41.4%)] from baseline to the end of intervention. No significant differences were observed between the groups in lean body mass, phase angle, C-reactive protein, and serum phosphorus and potassium levels. In terms of improving albumin, the subgroup analyses show that ONS use seems to be more inclined to three variations: HD patients, short-term use, and non-intradialytic supplementation. Conclusion: In conclusion, ONS use can improve the nutritional status of patients on dialysis in terms of their serum albumin, BMI, and HGS without significant effects on serum phosphorus, potassium, and C-reactive protein levels. However, it remains uncertain whether these results translate to improvement in clinically relevant outcomes. Large-scale high-quality studies are still required in this population.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFF1100604/2022YFF1100601)
This publication has 67 references indexed in Scilit:
- Serum Albumin as a Predictor of Mortality in Peritoneal Dialysis: Comparisons With HemodialysisAmerican Journal of Kidney Diseases, 2011
- A Novel Amino Acids Oral Supplementation in Hemodialysis Patients: a Pilot StudyRenal Failure, 2011
- Association Between Body Mass and Mortality in Maintenance Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2010
- Adiposity and insulin resistance in nondiabetic hemodialysis patients: effects of high energy supplementationThe American Journal of Clinical Nutrition, 2009
- Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patientsThe American Journal of Clinical Nutrition, 2009
- Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment CostsJournal of Renal Nutrition, 2007
- Nutritional Parameters and Mortality in Incident Hemodialysis PatientsJournal of Renal Nutrition, 2006
- Multinutrient Oral Supplements and Tube Feeding in Maintenance Dialysis: A Systematic Review and Meta-AnalysisAmerican Journal of Kidney Diseases, 2005
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Amino acid and albumin losses during hemodialysisKidney International, 1994